Literature DB >> 8635216

Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro.

A Hultgårdh-Nilsson1, B Cercek, J W Wang, S Naito, C Lövdahl, B Sharifi, J S Forrester, J A Fagin.   

Abstract

Ets-1 regulates the transcription of several genes encoding extracellular matrix proteins (ie, osteopontin and tenascin) as well as enzymes involved in degradation and remodeling of the extracellular matrix (ie, stromelysin and urokinase plasminogen activator). In the present study, we investigated the regulation of c-ets-1 in cultured rat vascular smooth muscle cells as well as in the arterial wall after balloon injury in vivo. Serum-starved smooth muscle cells exposed to serum for various time points express a major c-ets-1 mRNA transcript of 5.3 kb and minor bands of 4.0 and 2.5 kb with a peak at 2 hours after stimulation. These effects were concentration dependent. Western blotting revealed an increase in 55- and 40-kD immunoreactive ets-1 proteins in cells treated with serum for 2 hours, and binding to an oligonucleotide containing the ets-1 consensus cis-acting motif was demonstrated by electrophoretic mobility shift assay. Ets-1 mRNA abundance was induced with a peak at 2 hours after stimulation with platelet-derived growth factor-BB and with angiotensin II. There was a distinct increase of ets-1 immunoreactivity in the inner layer of the media 2 hours after balloon catheter injury of rat arteries, which declined after 6 hours and returned to the basal level 1 day after vessel wall damage. Arterial c-ets-1 mRNA content was induced with an identical time course. These findings suggest that c-ets-1 may be of importance in the mitogenic signaling pathway of smooth muscle cells grown in culture. In addition, ets-1 may play a role in the activation of smooth muscle cells in vivo after mechanical injury of the vessel wall. Because the ets-1 transcription factor activates the gene expression of a number of mRNA species involved in matrix deposition and degradation, these data are compatible with a role for ets-1 in vascular remodeling and/or cell migration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635216     DOI: 10.1161/01.res.78.4.589

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  30 in total

1.  Role of the Ets-1 transcription factor during activation of rat hepatic stellate cells in culture.

Authors:  T Knittel; D Kobold; J Dudas; B Saile; G Ramadori
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.

Authors:  Wenguang Feng; Dongqi Xing; Ping Hua; Yun Zhang; Yiu-Fai Chen; Suzanne Oparil; Edgar A Jaimes
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

3.  Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension.

Authors:  Wenguang Feng; Phillip Chumley; Minolfa C Prieto; Kayoko Miyada; Dale M Seth; Huma Fatima; Ping Hua; Gabriel Rezonzew; Paul W Sanders; Edgar A Jaimes
Journal:  Hypertension       Date:  2015-01-26       Impact factor: 10.190

4.  The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling.

Authors:  Yumei Zhan; Lei Yuan; Maiko Kondo; Peter Oettgen
Journal:  Am J Hypertens       Date:  2010-08-05       Impact factor: 2.689

5.  Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling.

Authors:  Yumei Zhan; Courtney Brown; Elizabeth Maynard; Aleksandra Anshelevich; Weihua Ni; I-Cheng Ho; Peter Oettgen
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

Review 6.  The pathological roles of environmental and redox stresses in cardiovascular diseases.

Authors:  Sahoko Ichihara
Journal:  Environ Health Prev Med       Date:  2012-12-29       Impact factor: 3.674

7.  Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization.

Authors:  Daisuke Watanabe; Hitoshi Takagi; Kiyoshi Suzuma; Izumi Suzuma; Hideyasu Oh; Hirokazu Ohashi; Seiji Kemmochi; Akiyoshi Uemura; Tomonari Ojima; Eri Suganami; Noriko Miyamoto; Yasufumi Sato; Yoshihito Honda
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.

Authors:  Wenguang Feng; Phillip Chumley; Ping Hua; Gabriel Rezonzew; David Jaimes; Madison W Duckworth; Dongqi Xing; Edgar A Jaimes
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

Review 9.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

10.  Alterations in transcriptional responses associated with vascular aging.

Authors:  Yumei Zhan; Lei Yuan; Peter Oettgen
Journal:  J Inflamm (Lond)       Date:  2009-05-21       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.